Latest Financial Results News

Stanmore Resources reports a challenging first half of 2025 with lower coal prices and significant wet weather impacting production and earnings, but maintains safety excellence and cost discipline while preparing for a second-half recovery and growth projects.

Stanmore Resources delivered resilient first-half 2025 results despite severe wet weather, maintaining solid production and financial metrics while suspending its interim dividend amid economic uncertainty.

Stanmore Resources Limited reported a net loss of US$50.5 million for the half-year ended June 2025, reversing a prior profit amid falling coal prices and operational disruptions from severe weather. The company’s underlying earnings also took a hit, reflecting challenging market conditions.

nib Holdings reported a solid FY25 with underlying operating profit of $239.2 million and 3.2% policyholder growth, driven by digital innovation and operational efficiencies. The Group’s strategic focus on core health insurance and adjacent services sets the stage for continued momentum into FY26.

nib Group reported solid FY25 results with revenue growth to $3.6 billion and a 9.4% rise in net profit after tax, while maintaining its full-year dividend at 29 cents per share. The company’s Australian private health insurance business achieved record policyholder growth amid ongoing claims inflation and operational efficiencies.

nib holdings limited reported a 9.4% increase in net profit after tax to $198.6 million for FY25, alongside a 7.8% rise in group revenue to $3.6 billion. Despite a dip in underlying operating profit, the company declared a fully franked final dividend, maintaining its full-year payout at 29 cents per share.

Underwood Capital Limited has reported a return to profitability for the year ended 30 June 2025, driven by gains in its listed securities portfolio and a strategic share buyback that enhanced net tangible asset backing per share.

Nuix Limited reported an 8% rise in Annualised Contract Value for FY25, driven by a remarkable 132% growth in its Nuix Neo platform. Despite flat revenue, the company achieved a 24.5% increase in Cash EBITDA and outlined a confident outlook for FY26.

Lindsay Australia Limited reported a resilient FY25 with revenue up 5.6% to $849.8 million and underlying EBITDA of $81.4 million, despite margin pressures from competitive pricing and rising costs. The company successfully integrated the SRT acquisition, expanding its national refrigerated logistics network.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.

Lindsay Australia Limited reported a 5.6% revenue increase to A$849.8 million for FY25 but saw net profit after tax fall 36.2% to A$17.39 million. The company declared a fully franked final dividend of 1.5 cents per share and strengthened its national refrigerated logistics footprint through key acquisitions.